Peter Howard Rheinstein (born September 7, 1943) is an American physician, lawyer, author, and administrator (both private and governmental). He was an official of the Food and Drug Administration (FDA) from 1974 to 1999.
Education Rheinstein, a General Motors Scholar, received a B.A. with high honors from Michigan State University in 1963, an M.S. in mathematics from Michigan State University in 1964, an M.D. from Johns Hopkins University in 1967, and a J.D. from the University of Maryland School of Law in 1973. At Michigan State University, Rheinstein was noted for his facility in mathematics.Steven G. Krantz. Mathematical Apocrypha: Stories and Anecdotes of Mathematicians and the Mathematical. The Mathematical Association of America (July 15, 2002) pp187-188
Food and Drug Administration Rheinstein was director of the Drug Advertising and Labeling Division, Food and Drug Administration, Rockville (1974-1982).VICTOR COHN. FALSE ADS CHARGED U. S. Impounds Millions of Birth Control Pills. Los Angeles Times. Jan 1, 1975, p A1F.D.A. Seized 25 Million Birth Control Pills in Dispute Over Advertisements. NY Times Jan. 1, 1975 He was acting deputy director Office of Drugs (1982–83), acting director Office of Drugs (1983–84), director Office of Drug Standards (1984–90),SURGEONS' MARKERS CITED FOR INFECTIONS. Philadelphia Inquirer. July 23, 1987BARRY MEIER. Diet-Pill Death Raises Questions On F.D.A. Role. New York Times August 4, 1990 and director medicine staff Office Health Affairs (1990–99).WILL PEOPLE COUGH UP $50 FOR $5 DRUG? ORGANIDIN'S MAKERS REPLACED AN INGREDIENT WITH ONE THAT'S AVAILABLE OVER THE COUNTER. THEY KEPT THE PRICE. Philadelphia Inquirer. Oct 14, 1994 A2.Hospitals' Fatal Mistakes Repeated Elsewhere. Beaver County Times. Oct 24, 1993 While at the FDA, Rheinstein developed precedents for Food and Drug Administration regulation of prescription drug promotion, initiated FDA’s first patient medication information program, implemented the Drug Price Competition and Patent Term Restoration Act of 1984, and authored medication goals for Healthy People 2000 and 2010. Peter Rheinstein. The Wrong Way to Control Drug Prices. Washington Times April 19, 2016Dylan Scott. The untold story of TV's first prescription drug ad. THE WEEK December 28, 2015 Judy Woodruff interviewed Rheinstein about generic drug safety on the McNeil-Lehrer NewsHour on December 11, 1985.Judy Woodruff interviews Peter Rheinstein about generic drug safety on the McNeil-Lehrer NewsHour, 11 Dec 1985. Stone Phillips interviewed Rheinstein about drug labeling on Dateline NBC on March 31, 1992.Stone Phillips interviews Peter Rheinstein about drug labeling, Dateline NBC, March 31, 1992
Later career From 1999 to 2004, Rheinstein was senior vice president for medical and clinical affairs at Cell Works, Inc., in Baltimore. Among other projects, Cell Works wanted to develop a blood test for anthrax, similar to a system for cancer cells it produced. "It's something that companies like ours can incorporate into our diagnostic technology," Rheinstein told the Washington Times. Biodefense projects "create new technologies, the spin-offs of which can be commercialized into some pretty good things."Tom Ramstack. Germ research gets urgent; Bioterrorism fuels interest, funding of scientific projects. Washington Times. June 9, 2003 page 1. In 2000 Rheinstein became president of Severn Health Solutions in Severna Park, Maryland. In 2010 Rheinstein was named president of the Academy of Physicians in Clinical Research Academy of Physicians in Clinical Research - AMA Delegate's Report 2013 and in 2011 was named chairman of the American Board of Legal Medicine. Rheinstein was named chairman of the United States Adopted Names Council in 2012. Rheinstein is a member of Phi Kappa PhiPeter Rheinstein – Lawyer – Justia and vice president of the Intercultural Friends Foundation. Rheinstein is publisher of Discovery Medicine and chairman of MedData Foundation. He is past president of the Academy of Medicine of Washington, DC. Academy of Medicine of Washington, DC past officers Sarah Gonzalez interviewed Rheinstein for Planet Money, This Is Your Brain on Drug Ads, on September 8, 2021.Sarah Gonzalez interviews Peter Rheinstein for Planet Money, This is Your Brain on Drug Ads, 8 Sept 2021
Publications co-author of Human Organ Transplantation: Societal, Medical-Legal, Regulatory, and Reimbursement Issues. Health Administration Press, Ann Arbor, Michigan 1987. special editorial advisor, Good Housekeeping Guide to Medicines and Drugs, 1977–80 member editorial board Legal Aspects Medical Practice, 1981–89 member editorial board Drug Information Journal, 1982–86 publisher of Discovery Medicine, 2001-
External links Peter Rheinstein on Avvo.com Peter Rheinstein's biography from Who's Who in America Peter Rheinstein's recent AMA House of Delegate Articles Peter Rheinstein's recent AMA House of Delegate Articles (pages 7 and 8, May 2017)Peter Rheinstein's recent AMA House of Delegate Articles, November 2015Peter Rheinstein's recent AMA House of Delegate Articles, June 2015Peter Rheinstein AMA HOUSE OF DELEGATES APCR DELEGATE’S REPORT JUNE 7, 2020 Peter Rheinstein publications on Google Scholar Peter Rheinstein publications on Google Books Peter Rheinstein publications on PubMed Judy Woodruff interviews Peter Rheinstein about generic drug safety on the McNeil-Lehrer NewsHour, 11 Dec 1985 Stone Phillips interviews Peter Rheinstein about drug labeling, Dateline NBC, March 31, 1992 Sarah Gonzalez interviews Peter Rheinstein for Planet Money, This is Your Brain on Drug Ads, 8 Sept 2021 Peter Rheinstein. House drug bill dooms medical research. Detroit News 20 Nov 2019 Peter Rheinstein. Research protections will beat crises like COVID-19. Columbus Dispatch 11 Aug 2020 FHS student completes summer science course. Farmington Enterprise 8 Sept 1960 Peter Rheinstein's biography from American Men & Women of Science: A Biographical Directory of Today’s Leaders in Physical, Biological and Related Sciences(Vol. 12. 36th ed. 2018) Peter Rheinstein interviewed Slate.com naming new drugs Dr. Peter Rheinstein Receives the APCR 2024 President’s Award
References